ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
DEALING IN SECURITIES BY DIRECTORS, PRESCRIBED OFFICERS AND THE COMPANY SECRETARY OF THE
COMPANY
In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, disclosure is made of
the following information:
DIRECTORS OF THE COMPANY
Director : Stephen Bradley Saad
Date of transaction : 14 September 2022
Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities : 50 310
Class of securities : Ordinary shares
Grant price : R142.7808
Value of Transaction : R7 183 302.05
Nature of interest : Direct beneficial
Clearance obtained : Yes
Director : Sean Matthew Capazorio
Date of transaction : 14 September 2022
Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities : 22 851
Class of securities : Ordinary shares
Grant price : R142.7808
Value of Transaction : R3 262 684.06
Nature of interest : Direct beneficial
Clearance obtained : Yes
PRESCRIBED OFFICERS OF THE COMPANY
Prescribed Officer : Michael Guy Attridge
Date of transaction : 14 September 2022
Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities : 41 590
Class of securities : Ordinary shares
Grant price : R142.7808
Value of Transaction : R5 938 253.47
Nature of interest : Direct beneficial
Clearance obtained : Yes
Prescribed Officer : Reginald Haman
Date of transaction : 14 September 2022
Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities : 17 498
Class of securities : Ordinary shares
Grant price : R142.7808
Value of Transaction : R2 498 378.44
Nature of interest : Direct beneficial
Clearance obtained : Yes
Prescribed Officer : Reginald Haman
Date of transaction : 14 September 2022
Nature of transaction : Acceptance of deferred retention bonus shares (vesting after three, five
and 7 years in tranches of 24 000, 32 000 and 44 000 shares, respectively)
Number of securities : 100 000
Class of securities : Ordinary shares
Grant price : R142.7808
Value of Transaction : R14 278 080.00
Nature of interest : Direct beneficial
Clearance obtained : Yes
Prescribed Officer : Lorraine Angela Hill
Date of transaction : 14 September 2022
Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities : 18 215
Class of securities : Ordinary shares
Grant price : R142.7808
Value of Transaction : R2 600 752.27
Nature of interest : Direct beneficial
Clearance obtained : Yes
Prescribed Officer : Zizipho Mmango
Date of transaction : 14 September 2022
Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities : 17 498
Class of securities : Ordinary shares
Grant price : R142.7808
Value of Transaction : R2 498 378.44
Nature of interest : Direct beneficial
Clearance obtained : Yes
Prescribed Officer : Zizipho Mmango
Date of transaction : 14 September 2022
Nature of transaction : Acceptance of deferred retention bonus shares (vesting after three, five
and 7 years in tranches of 24 000, 32 000 and 44 000 shares, respectively)
Number of securities : 100 000
Class of securities : Ordinary shares
Grant price : R142.7808
Value of Transaction : R14 278 080.00
Nature of interest : Direct beneficial
Clearance obtained : Yes
Prescribed Officer : Mark Sardi
Date of transaction : 14 September 2022
Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities : 17 498
Class of securities : Ordinary shares
Grant price : R142.7808
Value of Transaction : R2 498 378.44
Nature of interest : Direct beneficial
Clearance obtained : Yes
COMPANY SECRETARY OF THE COMPANY
Company Secretary : Riaan Verster
Date of transaction : 14 September 2022
Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities : 7 558
Class of securities : Ordinary shares
Grant price : R142.7808
Value of Transaction : R1 079 137.29
Nature of interest : Direct beneficial
Clearance obtained : Yes
All acceptances of deferred bonus shares are deemed to be off-market trades.
Durban
15 September 2022
Sponsor
Investec Bank Limited